000 01504 a2200397 4500
005 20250513215146.0
264 0 _c20010118
008 200101s 0 0 eng d
022 _a0167-6806
024 7 _a10.1023/a:1006449931921
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aArnal, M
245 0 0 _aEnhancement of mdr1 gene expression in normal tissue adjacent to advanced breast cancer.
_h[electronic resource]
260 _bBreast cancer research and treatment
_cMay 2000
300 _a13-20 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aBreast
_xmetabolism
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCyclophosphamide
_xadministration & dosage
650 0 4 _aDoxorubicin
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aFluorouracil
_xadministration & dosage
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aGenes, MDR
_xgenetics
650 0 4 _aHumans
650 0 4 _aRNA
_xmetabolism
650 0 4 _aReverse Transcriptase Polymerase Chain Reaction
700 1 _aFranco, N
700 1 _aFargeot, P
700 1 _aRiedinger, J M
700 1 _aBrunet-Lecomte, P
700 1 _aLizard-Nacol, S
773 0 _tBreast cancer research and treatment
_gvol. 61
_gno. 1
_gp. 13-20
856 4 0 _uhttps://doi.org/10.1023/a:1006449931921
_zAvailable from publisher's website
999 _c10879068
_d10879068